| 000 | 01747 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513170702.0 | ||
| 264 | 0 | _c19990506 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0022-538X | ||
| 024 | 7 |
_a10.1128/JVI.73.4.3292-3300.1999 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVerschoor, E J | |
| 245 | 0 | 0 |
_aComparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance. _h[electronic resource] |
| 260 |
_bJournal of virology _cApr 1999 |
||
| 300 |
_a3292-300 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAIDS Vaccines _xchemistry |
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _ximmunology |
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp120 _ximmunology |
| 650 | 0 | 4 |
_aHIV-1 _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aISCOMs _ximmunology |
| 650 | 0 | 4 | _aImmunity, Cellular |
| 650 | 0 | 4 | _aMacaca mulatta |
| 650 | 0 | 4 |
_aPolysorbates _xpharmacology |
| 650 | 0 | 4 |
_aRecombinant Proteins _ximmunology |
| 650 | 0 | 4 |
_aSqualene _ximmunology |
| 700 | 1 | _aMooij, P | |
| 700 | 1 | _aOostermeijer, H | |
| 700 | 1 | _avan der Kolk, M | |
| 700 | 1 | _aten Haaft, P | |
| 700 | 1 | _aVerstrepen, B | |
| 700 | 1 | _aSun, Y | |
| 700 | 1 | _aMorein, B | |
| 700 | 1 | _aAkerblom, L | |
| 700 | 1 | _aFuller, D H | |
| 700 | 1 | _aBarnett, S W | |
| 700 | 1 | _aHeeney, J L | |
| 773 | 0 |
_tJournal of virology _gvol. 73 _gno. 4 _gp. 3292-300 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JVI.73.4.3292-3300.1999 _zAvailable from publisher's website |
| 999 |
_c10034152 _d10034152 |
||